A fresh study from the Medical University of South Carolina is generating new worries about fish oil supplements, particularly for individuals suffering repeated mild traumatic brain injuries. Publishing in the journal Cell Reports, scientists indicate that these commonly used supplements, frequently marketed as brain-protective, might actually hinder recovery after injury. The investigation was directed by neuroscientist Onder Albayram, Ph.D., an associate professor at MUSC and a member of the National Trauma Society Committee. His group concentrated on the biological mechanisms involved in mending blood vessels in the brain following trauma. Surging Popularity of Omega-3 Supplements Interest in omega-3 fatty acids, the primary elements of fish oil, has been expanding quickly. According to Fortune Business Insights, these supplements are now appearing not just in capsules but also in beverages, dairy substitutes, and snack items. This spike in popularity does not astonish Albayram. "Fish oil supplements are ubiquitous, and people consume them for various reasons, frequently without a clear grasp of their long-term consequences," he stated. "But regarding neuroscience, we still do not know whether the brain possesses resilience or resistance to this supplement. That is why ours is the first such study in the area." Albayram partnered with Eda Karakaya, Ph.D., Adviye Ergul, M.D., Ph.D., and numerous other researchers at MUSC and collaborating institutions. Among them was Semir Beyaz, Ph.D., at the Cold Spring Harbor Laboratory Cancer Center in New York. The group uncovered what they term a context-dependent metabolic vulnerability. Simply put, this implies that alterations in how cells utilize energy may diminish the brain's capacity to recover under specific conditions. This vulnerability seems connected to the accumulation of eicosapentaenoic acid, or EPA, one of the principal omega-3 fatty acids present in fish oil. In their experimental models, elevated levels of EPA in the brain were correlated with weaker repair following injury. Albayram observed that not all omega-3s act identically. Docosahexaenoic acid, or DHA, is widely recognized for its beneficial role in the brain and constitutes a major part of neuronal membranes. EPA, however, follows a distinct pathway. It is less integrated into brain structures, and its effects can differ based on how long it remains present and the surrounding biological conditions. Consequently, the long-term impact of omega-3 consumption on brain recovery and blood vessel adaptation has stayed uncertain. To better comprehend these effects, the scientists employed a series of models to link diet, brain function, and healing. In mice, they investigated how prolonged fish oil use affected the brain's reaction to repeated mild head impacts. Their emphasis was on signals related to blood vessel stability and repair. They also examined human brain microvascular endothelial cells, which constitute part of the barrier between the brain and the bloodstream. In these cells, EPA, but not DHA, was associated with diminished repair capacity, aligning with the results from the animal models. To extend the findings to real-world disease, the team analyzed postmortem brain tissue from individuals diagnosed with chronic traumatic encephalopathy (CTE) who had a history of repeated brain injury. The researchers characterized the results as having "implications for precision nutrition, therapeutic strategies and the design of dietary interventions targeting brain injury and neurodegeneration." The study pinpointed several major patterns, which are summarized below along with simplified explanations.
1.EPA-driven neurovascular instability triggers perivascular tauopathy and cognitive decline following TBI. "In a sensitive brain state modeled in mice, long-term fish oil supplementation revealed a delayed vulnerability. The animals showed poorer neurological and spatial learning performance over time, together with clear evidence of vascular-associated tau accumulation in the cortex, linking impaired recovery to neurovascular dysfunction and perivascular tau pathology," Albayram noted.
2. EPA reprograms cortical transcriptional responses and suppresses angiogenic signaling following traumatic brain injury. "In the injured cortex, the team observed a coordinated shift in gene programs that normally support vascular stability and repair," Albayram noted. "The pattern included reduced expression of genes tied to extracellular matrix organization and endothelial integrity, alongside broader changes consistent with altered lipid handling after injury."
3. EPA utilization under permissive metabolic conditions impairs angiogenesis and endothelial integrity, recapitulating post-traumatic brain injury cerebrovascular dysfunction. Albayram noted that in human brain microvascular endothelial cells, EPA did not act as a universal toxin. "Instead, when cells were placed in conditions that encouraged fatty acid engagement, EPA was associated with weaker angiogenic network formation and reduced endothelial barrier integrity, matching key features of the neurovascular repair deficit seen in vivo."
4.CTE brain reveals neurovascular and fatty acid metabolic reprogramming consistent with EPA-linked vulnerability. "In postmortem cortex from neuropathologically confirmed CTE cases with a history of repetitive brain injury, the researchers found evidence of disrupted fatty acid balance and broad transcriptional changes affecting vascular and metabolic pathways," Albayram noted. "This human arm was used to provide translational context, asking whether chronic disease tissue shows convergent signatures of altered lipid handling and reduced vascular stability."
Albayram emphasized that the study should not be viewed as a blanket warning against fish oil. "I am not claiming fish oil is good or bad in some universal way," he stated. "What our data highlight is that biology is context-dependent. We need to understand how these supplements behave in the body over time, rather than assuming the same effect applies to everyone." The researchers hope their work prompts a more careful examination of omega-3 supplementation, both in clinical settings and among the general public. 
Their experiments focused on a specific scenario, repeated mild brain injury, and used CTE tissue to provide supporting observations rather than direct proof of cause and effect. "As with any study, there are important boundaries," Albayram noted. "In the human CTE tissue, we can observe patterns, but we cannot prove what drove them. We also cannot capture every variable that shapes omega-3 handling in real life, including overall diet, health status and lifestyle." The team plans to continue investigating how EPA moves through the body, including how it is absorbed, transported, and distributed. They are especially interested in the mechanisms that control fatty acid movement. "This paper is a starting point," Albayram noted, "but it is an important one. It opens a new conversation about precision nutrition in neuroscience, and it gives the field a framework to ask better, more testable questions."